The First Hospital of Hebei Medical University — Shijiazhuang, Hebei

Public research footprint of The First Hospital of Hebei Medical University, compiled from the ClinicalTrials.gov public registry.

170

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Primary Membranous Nephropathy · Heart Failure · Acute Spinal Cord Injury (SCI) · Immune Thrombocytopenic Purpura (ITP)

Recently updated registry entries

NCT07277907 — Efficacy and Safety of Lubiprostone in the Treatment of Slow Transit Constipation (Recruiting)
NCT06937944 — Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to… (Recruiting)
NCT06350890 — Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The First Hospital of Hebei Medical University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.